Pink Sheet
Scrip
Medtech Insight
HBW Insight
Generics Bulletin
In Vivo
Pink Sheet
Scrip
Medtech Insight
HBW Insight
Generics Bulletin
In Vivo
Tekmira’s $1bn RNAi suit costs Alnylam $65m as firms kiss and make up
Nov 14 2012
•
By
Francesca Bruce
Keep up with the top pharma business news of the week. On the go.
Scrip brings you a weekly bulletin of top picks.
More from Anticancer
More from Therapeutic Category